Default company panoramic image

OzStar Therapeutics

A new combination treatment for type 2 diabetes using clinically validated and naturally-derived products

  • Stage Product In Development
  • Industry Healthcare Services
  • Location San Diego, CA, USA
  • Currency USD
  • Founded April 2010
  • Website

Company Summary

OzStar Therapeutics has developed a treatment for type 2 diabetes that controls blood glucose, reduces weight gain and improves the overall well-being of patients. Long-term and successful clinical case studies, a strong IP position and the support of leading diabetologists have positioned the company to seek investment for a pivotal clinical development program.


  • Default avatar
    Dr Nick Gorgani
    Chief Executive Officer

    Prior to founding OzStar, Nick worked for world-class research organizations such as Scripps Research Institute and Genentech/Roche. Nick holds a Bachelors in Chemical Eng, masters in medicine, PhD in immunology, and masters in drug development. Nick has led and contributed to a number of patentable discoveries. Nick is affiliated with the University of Adelaide as a clinical senior lecturer and with the University of Sydney as a senior lecturer.

  • Default avatar
    Dr Tim Hirst

    An entrepreneur and business angel with extensive experience in developing early stage life science companies in the UK and Australia. He has held the positions of Head & Professor of Microbiology at the University of Bristol, Deputy Vice Chancellor at the University of Sydney and CEO of ANU Connect Ventures – a Canberra based venture capital fund. He is currently the Executive Chairman of Gamma Vaccines Pty Ltd and Chairman of CIMTECH Pty Ltd.


  • Default avatar
    Shelston IP
    Default avatar
    Lawler Partners